Biotechnology
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Biotechnology
Jun 18, 2024, 23:25 |
Insight
The future of immuno-oncology discussion with Agenus at ESMO GI 2024
Agenus shared a post on LinkedIn: “Are you a physician attending ESMO GI 24? Join…
Jun 14, 2024, 06:30 |
Blog
David Fajgenbaum: So great to connect with so many leaders last week at I Am Biotech!
David Fajgenbaum, Associate Professor of Medicine at University of Pennsylvania School of Medicine, shared on X:…
May 17, 2024, 14:37 |
Blog
Sheo Mohan Singh: Celebrating with summer training participants
Sheo Mohan Singh, Director at International Centre for Stem Cells, Cancer and Biotechnology (ICSCCB) shared…
May 15, 2024, 10:13 |
Blog
Patient dosing has commenced in the Phase 1 clinical trial of SENTI-202 - Senti Biosciences
Tim Lu, Co-Founder and CEO at Senti Biosciences, shared the following post by Senti Biosciences…
May 15, 2024, 08:32 |
Blog
Tanja Obradovic: Private Biotech investment is on the steady rise reaching $3.1 billion in April
Tanja Obradovic, Vice President of Oncology Scientific Affairs at ICON, shared on LinkedIn: “Private Biotech investment is…
Apr 27, 2024, 08:15 |
Blog
Jacqueline Hess: Highlights coming out of Swiss Biotech Day 2024
Jacqueline Hess, Chair (Switzerland) of The Boardroom, shared on LinkedIn: “There are always many highlights…
Feb 28, 2024, 15:03 |
Blog
Cristina Jauset Gonzalez: Flagship Pioneering's newest stealth biotech start-up, FL102, is looking for its first two scientists!
Cristina Jauset Gonzalez, Associate at Flagship Pioneering, made the following post on LinkedIn: "Flagship Pioneering's…
Feb 17, 2024, 19:19 |
Blog
Don't miss out on two remarkable Keynotes at Moffitt's Business of Biotech Conference next Friday, Feb 23! - Moffitt Cancer Center
Moffitt Cancer Center shared on LinkedIn: “Don't miss out on two remarkable Keynotes at Moffitt's Business…
Jan 27, 2024, 22:42 |
Blog
John Houston: Thanks for the great write up on the exciting events happening at Arvinas!
John Houston, Chairperson, CEO and President at Arvinas (NASDAQ ARVN), shared the following post by…
Oct 31, 2023, 23:29 |
Blog
We’re excited to announce our new strategic partnership with Verily - Georgiamune Inc.
Georgiamune Inc. made the following post on LinkedIn: "We’re excited to announce our new strategic…
Oct 31, 2023, 10:23 |
Blog
Harout Semerjian: It was an honor to be appointed to the Biotechnology Innovation Organization’s Board of Directors, Emerging Companies Section
Harout Semerjian, President and CEO at GlycoMimetics, posted on LinkedIn: "It was an honor this…
Oct 11, 2023, 22:39 |
Opinion
Agenus completed the planned patient enrollment of its Phase 2 clinical trial evaluating investigational agents botensilimab (BOT) and balstilimab (BAL) in advanced colorectal cancer. - Agenus
All:
12
Posts:
1 - 100
ASCO IDEA - Life-changing experience for the early-career oncologists in LMICs
Gemma Peters: The new government has an opportunity to fix our broken cancer care system
Blending Science and Compassion: Exclusive Conversation with ASCO President-Elect Eric J. Small
OncoDaily at ASCO 2024: OncoDaily Party, Yvonne Award and much more
Tedros Adhanom Ghebreyesus received University of Nicosia’s Honorary Doctorate
Facebook
RSS Feed
Twitter
Linkedin
Youtube